[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"ApplicationsList":3,"ProductServiceList":39,"BasicInfo":275,"BlogDetail152Info":287},{"msg":4,"code":5,"data":6},"操作成功",0,[7,20,24,28,32,35],{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"parentName":8,"parentId":5,"orderNum":8,"ancestors":8,"id":9,"title":10,"excerpt":8,"content":8,"publishDate":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"productServiceId":8,"sort":11,"homeState":8,"homePic":8,"homeTitle":8,"homeDesc":8,"homeSort":8,"applicationsSubList":12,"productService":8},null,9,"Oligonucleotide Drug Synthesis",90,[13,16],{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"parentName":8,"parentId":9,"orderNum":8,"ancestors":8,"id":14,"title":15,"excerpt":8,"content":8,"publishDate":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"productServiceId":8,"sort":11,"homeState":8,"homePic":8,"homeTitle":8,"homeDesc":8,"homeSort":8,"applicationsSubList":8,"productService":8},19,"Oligonucleotide Synthesis and Modifications",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"parentName":8,"parentId":9,"orderNum":8,"ancestors":8,"id":17,"title":18,"excerpt":8,"content":8,"publishDate":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"productServiceId":8,"sort":19,"homeState":8,"homePic":8,"homeTitle":8,"homeDesc":8,"homeSort":8,"applicationsSubList":8,"productService":8},20,"Oligonucleotide biological evaluation platform",50,{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"parentName":8,"parentId":5,"orderNum":8,"ancestors":8,"id":21,"title":22,"excerpt":8,"content":8,"publishDate":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"productServiceId":8,"sort":23,"homeState":8,"homePic":8,"homeTitle":8,"homeDesc":8,"homeSort":8,"applicationsSubList":8,"productService":8},14,"Gene&Genome Editing",80,{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"parentName":8,"parentId":5,"orderNum":8,"ancestors":8,"id":25,"title":26,"excerpt":8,"content":8,"publishDate":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"productServiceId":8,"sort":27,"homeState":8,"homePic":8,"homeTitle":8,"homeDesc":8,"homeSort":8,"applicationsSubList":8,"productService":8},15,"Synthetic Biology",70,{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"parentName":8,"parentId":5,"orderNum":8,"ancestors":8,"id":29,"title":30,"excerpt":8,"content":8,"publishDate":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"productServiceId":8,"sort":31,"homeState":8,"homePic":8,"homeTitle":8,"homeDesc":8,"homeSort":8,"applicationsSubList":8,"productService":8},16,"Antibody Drug Discovery",60,{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"parentName":8,"parentId":5,"orderNum":8,"ancestors":8,"id":33,"title":34,"excerpt":8,"content":8,"publishDate":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"productServiceId":8,"sort":19,"homeState":8,"homePic":8,"homeTitle":8,"homeDesc":8,"homeSort":8,"applicationsSubList":8,"productService":8},17,"IVD Raw Material",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"parentName":8,"parentId":5,"orderNum":8,"ancestors":8,"id":36,"title":37,"excerpt":8,"content":8,"publishDate":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"productServiceId":8,"sort":38,"homeState":8,"homePic":8,"homeTitle":8,"homeDesc":8,"homeSort":8,"applicationsSubList":8,"productService":8},18,"Vaccine and Novel Therapy",40,{"msg":4,"code":5,"data":40},[41,80,116,158,169,184,194,218,247,271],{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":9,"title":42,"excerpt":8,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"sort":8,"createDate":8,"secondColor":8,"showOrderPic":8,"homeState":8,"homePic":8,"homeTitle":8,"homeDesc":8,"homeSort":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"serviceFeatureList":8,"productServiceSubList":43},"Gene Synthesis and Related Services",[44,51,56,61,66,70,75],{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":45,"parentId":9,"title":46,"subTitle":47,"excerpt":48,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"sort":8,"hotState":49,"newState":5,"type":50,"customerTestimonials":8,"productCatalog":8,"relatedTitles":8,"productService":8,"customerTestimonialsList":8,"relatedTitlesList":8,"serviceFeatureSubList":8,"productCatalogList":8},11,"Gene Synthesis","Custom gene synthesis solutions with optimized design and reliable quality.","GenCefe gene synthesis services - professional technical support, free codon optimization, fast delivery and 100% accuracy guarantee.",1,"服务",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":52,"parentId":9,"title":53,"subTitle":54,"excerpt":55,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"sort":8,"hotState":5,"newState":5,"type":50,"customerTestimonials":8,"productCatalog":8,"relatedTitles":8,"productService":8,"customerTestimonialsList":8,"relatedTitlesList":8,"serviceFeatureSubList":8,"productCatalogList":8},12,"Codon Optimization","Host-specific codon optimization to support efficient recombinant protein expression.","GenCefe has introduced advanced AI technology into codon optimization and independently developed the Codon Optimization Tool, which can significantly increase the protein expression level and success rate.",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":57,"parentId":9,"title":58,"subTitle":59,"excerpt":60,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"sort":8,"hotState":5,"newState":5,"type":50,"customerTestimonials":8,"productCatalog":8,"relatedTitles":8,"productService":8,"customerTestimonialsList":8,"relatedTitlesList":8,"serviceFeatureSubList":8,"productCatalogList":8},48,"Gene Fragments","Custom DNA fragments for flexible downstream assembly.","GenCefe offers DNA fragment synthesis service with strict QC standards and fast turnaround, saving time and budget for you.",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":62,"parentId":9,"title":63,"subTitle":64,"excerpt":65,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"sort":8,"hotState":5,"newState":5,"type":50,"customerTestimonials":8,"productCatalog":8,"relatedTitles":8,"productService":8,"customerTestimonialsList":8,"relatedTitlesList":8,"serviceFeatureSubList":8,"productCatalogList":8},49,"Subcloning & PCR Cloning","Custom Cloning Solutions for Tailored Plasmid Construction","GenCefe Biotech can help customers clone the target gene into any site of the specified vector to meet different needs.",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":19,"parentId":9,"title":67,"subTitle":68,"excerpt":69,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"sort":8,"hotState":5,"newState":5,"type":50,"customerTestimonials":8,"productCatalog":8,"relatedTitles":8,"productService":8,"customerTestimonialsList":8,"relatedTitlesList":8,"serviceFeatureSubList":8,"productCatalogList":8},"Plasmid Preparation","Flexible plasmid preparation tailored to your specific needs.","GenCefe provides high-quality plasmid preparation from micrograms to grams, with strict QC for batch consistency.",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":71,"parentId":9,"title":72,"subTitle":73,"excerpt":74,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"sort":8,"hotState":5,"newState":5,"type":50,"customerTestimonials":8,"productCatalog":8,"relatedTitles":8,"productService":8,"customerTestimonialsList":8,"relatedTitlesList":8,"serviceFeatureSubList":8,"productCatalogList":8},51,"Mutagenesis","Custom DNA mutagenesis for precise sequence modifications.","GenCefe provides various site-directed mutagenesis services,including insertions,deletions,and substitutions,we can precisely introduce mutations into DNA sequences and deliver 100% accuracy sequences",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":76,"parentId":9,"title":77,"subTitle":78,"excerpt":79,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"sort":8,"hotState":5,"newState":5,"type":50,"customerTestimonials":8,"productCatalog":8,"relatedTitles":8,"productService":8,"customerTestimonialsList":8,"relatedTitlesList":8,"serviceFeatureSubList":8,"productCatalogList":8},52,"Gene Synthesis Case Studies","","GenCefe's experienced team has successfully delivered various difficult gene sequences, including GC-rich, repeated, ultra-long genes, etc.",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":49,"title":81,"excerpt":8,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"sort":8,"createDate":8,"secondColor":8,"showOrderPic":8,"homeState":8,"homePic":8,"homeTitle":8,"homeDesc":8,"homeSort":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"serviceFeatureList":8,"productServiceSubList":82},"RNAi Products & RNA Synthesis",[83,88,94,99,104,109,112],{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":84,"parentId":49,"title":85,"subTitle":86,"excerpt":87,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"sort":8,"hotState":5,"newState":5,"type":50,"customerTestimonials":8,"productCatalog":8,"relatedTitles":8,"productService":8,"customerTestimonialsList":8,"relatedTitlesList":8,"serviceFeatureSubList":8,"productCatalogList":8},13,"Custom siRNA Synthesis","Custom siRNA Synthesis and Modifications for Diverse Research Needs","GenCefe provides siRNA design and custom synthesis, including standard siRNA oligos and modified siRNA oligos, to meet customers'specific needs.",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":89,"parentId":49,"title":90,"subTitle":91,"excerpt":92,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"sort":8,"hotState":49,"newState":5,"type":93,"customerTestimonials":8,"productCatalog":8,"relatedTitles":8,"productService":8,"customerTestimonialsList":8,"relatedTitlesList":8,"serviceFeatureSubList":8,"productCatalogList":8},22,"Pre-Designed siRNA Sets","Ready-to-Order siRNA Sets for Targeted Gene-Silencing Research","GenCefe Biotech provides 50,000+ pre-designed siRNA sets for human, rat, and mouse. Guaranteed gene silencing, free control siRNA.","产品",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":95,"parentId":49,"title":96,"subTitle":97,"excerpt":98,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"sort":8,"hotState":5,"newState":5,"type":50,"customerTestimonials":8,"productCatalog":8,"relatedTitles":8,"productService":8,"customerTestimonialsList":8,"relatedTitlesList":8,"serviceFeatureSubList":8,"productCatalogList":8},56,"Custom miRNA Mimic\u002FInhibitor","Custom miRNA Mimics and Inhibitors for In Vitro and In Vivo Research","GenCefe has developed various miRNA mimics for gain-of-function studies and inhibitors for loss-of-function studies, with different options for both in vitro and in vivo experiments.",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":100,"parentId":49,"title":101,"subTitle":102,"excerpt":103,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"sort":8,"hotState":5,"newState":5,"type":50,"customerTestimonials":8,"productCatalog":8,"relatedTitles":8,"productService":8,"customerTestimonialsList":8,"relatedTitlesList":8,"serviceFeatureSubList":8,"productCatalogList":8},58,"sgRNA Synthesis","Custom gRNA Synthesis and Design with Flexible Options and Quality Control","GenCefe provides sgRNA design and chemical synthesis services. Deliverables are tested by mass spectrometry for sequence accuracy and purified by HPLC.",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":105,"parentId":49,"title":106,"subTitle":107,"excerpt":108,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"sort":8,"hotState":5,"newState":49,"type":50,"customerTestimonials":8,"productCatalog":8,"relatedTitles":8,"productService":8,"customerTestimonialsList":8,"relatedTitlesList":8,"serviceFeatureSubList":8,"productCatalogList":8},59,"circRNA","Flexible circRNA Synthesis with Chemical and IVT Platforms.","GenCefe Biotech offers both chemical and IVT synthesis of circRNA, enabling customized solutions with flexible lengths and purity to meet diverse research needs.",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":31,"parentId":49,"title":110,"subTitle":78,"excerpt":111,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"sort":8,"hotState":5,"newState":5,"type":50,"customerTestimonials":8,"productCatalog":8,"relatedTitles":8,"productService":8,"customerTestimonialsList":8,"relatedTitlesList":8,"serviceFeatureSubList":8,"productCatalogList":8},"RNA Modifications","GenCefe Biotech provides comprehensive RNA modification, labeling, and conjugation services to meet the needs of different types of nucleic acid drug delivery.",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":113,"parentId":49,"title":114,"subTitle":78,"excerpt":115,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"sort":8,"hotState":5,"newState":5,"type":50,"customerTestimonials":8,"productCatalog":8,"relatedTitles":8,"productService":8,"customerTestimonialsList":8,"relatedTitlesList":8,"serviceFeatureSubList":8,"productCatalogList":8},61,"RNA QC Standards","GenCefe Biotech is committed to providing high-quality oligonucleotide products and services; we perform HPLC detection and provide COA files for all of our oligonucleotide products by default. ",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":117,"title":118,"excerpt":8,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"sort":8,"createDate":8,"secondColor":8,"showOrderPic":8,"homeState":8,"homePic":8,"homeTitle":8,"homeDesc":8,"homeSort":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"serviceFeatureList":8,"productServiceSubList":119},2,"DNA Oligo Synthesis",[120,125,129,134,138,142,146,151,154],{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":121,"parentId":117,"title":122,"subTitle":123,"excerpt":124,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"sort":8,"hotState":5,"newState":5,"type":50,"customerTestimonials":8,"productCatalog":8,"relatedTitles":8,"productService":8,"customerTestimonialsList":8,"relatedTitlesList":8,"serviceFeatureSubList":8,"productCatalogList":8},62,"Custom DNA Oligo Synthesis","Custom DNA Oligo Synthesis with Flexible Specifications and Reliable Quality","GenCefe provides high-quality oligonucleotide synthesis and modification services, including standard primers, qPCR primers and probes, NGS primers, etc. ",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":126,"parentId":117,"title":127,"subTitle":78,"excerpt":128,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"sort":8,"hotState":5,"newState":5,"type":50,"customerTestimonials":8,"productCatalog":8,"relatedTitles":8,"productService":8,"customerTestimonialsList":8,"relatedTitlesList":8,"serviceFeatureSubList":8,"productCatalogList":8},63,"DNA Oligo Modifications","GenCefe provides comprehensive modifications, including biotin, digoxigenin, fluorescence, phosphorylation, phosphorothioates, amino Linkers, etc.",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":130,"parentId":117,"title":131,"subTitle":132,"excerpt":133,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"sort":8,"hotState":5,"newState":5,"type":50,"customerTestimonials":8,"productCatalog":8,"relatedTitles":8,"productService":8,"customerTestimonialsList":8,"relatedTitlesList":8,"serviceFeatureSubList":8,"productCatalogList":8},64,"qPCR Primers & Probes","Custom qPCR primers and probes with flexible specifications and reliable quality.","GenCefe Biotech has established an advanced oligo synthesis and modification technology platform with an experienced technical team to provide customized qPCR primers and probes.",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":135,"parentId":117,"title":136,"subTitle":78,"excerpt":137,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"sort":8,"hotState":5,"newState":5,"type":50,"customerTestimonials":8,"productCatalog":8,"relatedTitles":8,"productService":8,"customerTestimonialsList":8,"relatedTitlesList":8,"serviceFeatureSubList":8,"productCatalogList":8},65,"NGS Primers & Probes","GenCefe Biotech offers NGS adapters, blockers, capture probes, and multiplex PCR primers using advanced oligo synthesis and modification technology.",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":139,"parentId":117,"title":140,"subTitle":78,"excerpt":141,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"sort":8,"hotState":5,"newState":5,"type":50,"customerTestimonials":8,"productCatalog":8,"relatedTitles":8,"productService":8,"customerTestimonialsList":8,"relatedTitlesList":8,"serviceFeatureSubList":8,"productCatalogList":8},66,"FISH Probes","GenCefe Biotech offers custom FISH probe design and synthesis with various fluorescent labels (Cy3, Cy5, FAM), HPLC purification, and expert technical support.",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":143,"parentId":117,"title":144,"subTitle":78,"excerpt":145,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"sort":8,"hotState":5,"newState":5,"type":50,"customerTestimonials":8,"productCatalog":8,"relatedTitles":8,"productService":8,"customerTestimonialsList":8,"relatedTitlesList":8,"serviceFeatureSubList":8,"productCatalogList":8},67,"STR Primers"," GenCefe offers high-quality fluorescently labeled STR primers for forensic applications, with optimized dyes, purification processes, and strict quality standards.",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":147,"parentId":117,"title":148,"subTitle":149,"excerpt":150,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"sort":8,"hotState":5,"newState":49,"type":50,"customerTestimonials":8,"productCatalog":8,"relatedTitles":8,"productService":8,"customerTestimonialsList":8,"relatedTitlesList":8,"serviceFeatureSubList":8,"productCatalogList":8},68,"Circular DNA","Custom single-stranded circular DNA synthesis tailored to your research needs. ","GenCefe Biotech has successfully developed single-stranded circular DNA (CssDNA) synthesis technology, providing researchers in gene expression, gene therapy, and vaccine development with a powerful new tool. ",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":27,"parentId":117,"title":152,"subTitle":78,"excerpt":153,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"sort":8,"hotState":5,"newState":5,"type":50,"customerTestimonials":8,"productCatalog":8,"relatedTitles":8,"productService":8,"customerTestimonialsList":8,"relatedTitlesList":8,"serviceFeatureSubList":8,"productCatalogList":8},"PCR Assay Design and Development","GenCefe Biotech combines 10+ years oligo synthesis experience with bioinformatics and AI to offer one-step PCR assay design, synthesis, and verification services.",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":155,"parentId":117,"title":156,"subTitle":78,"excerpt":157,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"sort":8,"hotState":5,"newState":5,"type":50,"customerTestimonials":8,"productCatalog":8,"relatedTitles":8,"productService":8,"customerTestimonialsList":8,"relatedTitlesList":8,"serviceFeatureSubList":8,"productCatalogList":8},71,"DNA Oligo QC","GenCefe Biotech has a strict ISO9001 & ISO13485-certified QC system for oligos, offering standard and customized QC for research and IVD applications.",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":159,"title":160,"excerpt":8,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"sort":8,"createDate":8,"secondColor":8,"showOrderPic":8,"homeState":8,"homePic":8,"homeTitle":8,"homeDesc":8,"homeSort":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"serviceFeatureList":8,"productServiceSubList":161},3,"IVT mRNA Synthesis",[162,166],{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":163,"parentId":159,"title":164,"subTitle":78,"excerpt":165,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"sort":8,"hotState":5,"newState":5,"type":50,"customerTestimonials":8,"productCatalog":8,"relatedTitles":8,"productService":8,"customerTestimonialsList":8,"relatedTitlesList":8,"serviceFeatureSubList":8,"productCatalogList":8},74,"Custom IVT mRNA Synthesis Services","GenCefe Biotech provides custom IVT mRNA synthesis services for research and therapeutic development.",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":17,"parentId":159,"title":167,"subTitle":78,"excerpt":168,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"sort":8,"hotState":49,"newState":5,"type":93,"customerTestimonials":8,"productCatalog":8,"relatedTitles":8,"productService":8,"customerTestimonialsList":8,"relatedTitlesList":8,"serviceFeatureSubList":8,"productCatalogList":8},"Off-the-shelf mRNA Products","GenCefe Biotech offers high-quality off-the-shelf products, including mRNA and circRNA, with rigorous QC for purity, activity, and stability—saving you time and costs. ",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":170,"title":171,"excerpt":8,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"sort":8,"createDate":8,"secondColor":8,"showOrderPic":8,"homeState":8,"homePic":8,"homeTitle":8,"homeDesc":8,"homeSort":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"serviceFeatureList":8,"productServiceSubList":172},6,"CRISPR Cas9",[173,176,180],{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":174,"parentId":170,"title":101,"subTitle":78,"excerpt":175,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"sort":8,"hotState":5,"newState":5,"type":50,"customerTestimonials":8,"productCatalog":8,"relatedTitles":8,"productService":8,"customerTestimonialsList":8,"relatedTitlesList":8,"serviceFeatureSubList":8,"productCatalogList":8},34,"GenCefe Biotech provides customizable gRNA synthesis services, including sgRNA for CRISPR-Cas9 applications and pegRNA for precise genome editing and prime editing workflows.",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":177,"parentId":170,"title":178,"subTitle":78,"excerpt":179,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"sort":8,"hotState":5,"newState":5,"type":50,"customerTestimonials":8,"productCatalog":8,"relatedTitles":8,"productService":8,"customerTestimonialsList":8,"relatedTitlesList":8,"serviceFeatureSubList":8,"productCatalogList":8},35,"ssDNA Synthesis Services","GenCefe Biotech offers high-purity ssDNA synthesis up to several kilobases, with minimal double-stranded DNA residues, supporting cell-based and in vivo genome editing research.",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":181,"parentId":170,"title":182,"subTitle":78,"excerpt":183,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"sort":8,"hotState":5,"newState":5,"type":50,"customerTestimonials":8,"productCatalog":8,"relatedTitles":8,"productService":8,"customerTestimonialsList":8,"relatedTitlesList":8,"serviceFeatureSubList":8,"productCatalogList":8},36,"sgRNA library","CRISPR sgRNA libraries support high-throughput functional genomics screening by linking gene perturbation to phenotypic analysis for target discovery and validation.",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":185,"title":186,"excerpt":8,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"sort":8,"createDate":8,"secondColor":8,"showOrderPic":8,"homeState":8,"homePic":8,"homeTitle":8,"homeDesc":8,"homeSort":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"serviceFeatureList":8,"productServiceSubList":187},10,"Recombinant Antibody",[188,191],{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":189,"parentId":185,"title":190,"subTitle":78,"excerpt":78,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"sort":8,"hotState":5,"newState":49,"type":50,"customerTestimonials":8,"productCatalog":8,"relatedTitles":8,"productService":8,"customerTestimonialsList":8,"relatedTitlesList":8,"serviceFeatureSubList":8,"productCatalogList":8},72,"Recombinant Monoclonal Antibody Services",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":192,"parentId":185,"title":193,"subTitle":78,"excerpt":78,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"sort":8,"hotState":5,"newState":5,"type":50,"customerTestimonials":8,"productCatalog":8,"relatedTitles":8,"productService":8,"customerTestimonialsList":8,"relatedTitlesList":8,"serviceFeatureSubList":8,"productCatalogList":8},73,"Large-Scale Recombinant Antibody\u002FProtein Production",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":195,"title":196,"excerpt":8,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"sort":8,"createDate":8,"secondColor":8,"showOrderPic":8,"homeState":8,"homePic":8,"homeTitle":8,"homeDesc":8,"homeSort":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"serviceFeatureList":8,"productServiceSubList":197},5,"Recombinant Protein",[198,202,206,210,214],{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":199,"parentId":195,"title":200,"subTitle":78,"excerpt":201,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"sort":8,"hotState":5,"newState":5,"type":93,"customerTestimonials":8,"productCatalog":8,"relatedTitles":8,"productService":8,"customerTestimonialsList":8,"relatedTitlesList":8,"serviceFeatureSubList":8,"productCatalogList":8},23,"Cell Free Expression","GenCefe offers a cell-free protein expression system for proteins that are difficult to express in conventional systems, including membrane proteins, toxic proteins, and proteins requiring non-standard amino acids.",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":203,"parentId":195,"title":204,"subTitle":78,"excerpt":205,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"sort":8,"hotState":5,"newState":5,"type":50,"customerTestimonials":8,"productCatalog":8,"relatedTitles":8,"productService":8,"customerTestimonialsList":8,"relatedTitlesList":8,"serviceFeatureSubList":8,"productCatalogList":8},38,"Bacterial Expression","GenCefe provides E. coli–based protein expression services with optimization of gene design, vectors, fusion tags, and expression conditions to improve protein yield and solubility.",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":207,"parentId":195,"title":208,"subTitle":78,"excerpt":209,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"sort":8,"hotState":5,"newState":5,"type":50,"customerTestimonials":8,"productCatalog":8,"relatedTitles":8,"productService":8,"customerTestimonialsList":8,"relatedTitlesList":8,"serviceFeatureSubList":8,"productCatalogList":8},53,"Mammalian Cell Expression","GenCefe’s mammalian expression systems (CHO and HEK293) produce recombinant proteins and antibodies with proper post-translational modifications for functionally relevant applications.",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":211,"parentId":195,"title":212,"subTitle":78,"excerpt":213,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"sort":8,"hotState":5,"newState":5,"type":50,"customerTestimonials":8,"productCatalog":8,"relatedTitles":8,"productService":8,"customerTestimonialsList":8,"relatedTitlesList":8,"serviceFeatureSubList":8,"productCatalogList":8},54,"Insect Cell\u002FBaculovirus Expression","The insect cell\u002Fbaculovirus system enables eukaryotic protein expression with complex folding and post-translational modifications, suitable for research and development use.",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":215,"parentId":195,"title":216,"subTitle":78,"excerpt":217,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"sort":8,"hotState":5,"newState":5,"type":50,"customerTestimonials":8,"productCatalog":8,"relatedTitles":8,"productService":8,"customerTestimonialsList":8,"relatedTitlesList":8,"serviceFeatureSubList":8,"productCatalogList":8},55,"Yeast Expression","Yeast-based expression systems provide a cost-effective option for recombinant protein production, supported by sequence and expression optimization strategies.",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":219,"title":220,"excerpt":8,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"sort":8,"createDate":8,"secondColor":8,"showOrderPic":8,"homeState":8,"homePic":8,"homeTitle":8,"homeDesc":8,"homeSort":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"serviceFeatureList":8,"productServiceSubList":221},7,"Peptide Synthesis & Modification",[222,225,228,231,235,239,243],{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":14,"parentId":219,"title":223,"subTitle":78,"excerpt":224,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"sort":8,"hotState":5,"newState":5,"type":50,"customerTestimonials":8,"productCatalog":8,"relatedTitles":8,"productService":8,"customerTestimonialsList":8,"relatedTitlesList":8,"serviceFeatureSubList":8,"productCatalogList":8},"Custom Peptide Synthesis","GenCefe Biotech uses solid- and liquid-phase peptide synthesis to deliver high-quality custom, modified, labeled, cyclized peptides, glycopeptides, and libraries.",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":36,"parentId":219,"title":226,"subTitle":78,"excerpt":227,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"sort":8,"hotState":5,"newState":5,"type":50,"customerTestimonials":8,"productCatalog":8,"relatedTitles":8,"productService":8,"customerTestimonialsList":8,"relatedTitlesList":8,"serviceFeatureSubList":8,"productCatalogList":8},"Modified\u002FFluorescent Labeled Peptides","GenCefe provides over 300 different peptide modification groups, including: N-\u002FC-terminal modifications, fluorescent labeling, cyclic peptides, biotin labeling, etc.",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":33,"parentId":219,"title":229,"subTitle":78,"excerpt":230,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"sort":8,"hotState":5,"newState":5,"type":50,"customerTestimonials":8,"productCatalog":8,"relatedTitles":8,"productService":8,"customerTestimonialsList":8,"relatedTitlesList":8,"serviceFeatureSubList":8,"productCatalogList":8},"Stable Isotope-Labeled Peptides","GenCefe offers custom stable isotope-labeled peptides by incorporating isotope-labeled amino acids like C and N directly during synthesis, labeling the entire peptide chain.",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":232,"parentId":219,"title":233,"subTitle":78,"excerpt":234,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"sort":8,"hotState":5,"newState":5,"type":50,"customerTestimonials":8,"productCatalog":8,"relatedTitles":8,"productService":8,"customerTestimonialsList":8,"relatedTitlesList":8,"serviceFeatureSubList":8,"productCatalogList":8},44,"Cyclic Peptide Synthesis","GenCefe Biotech provides clyclic peptide synthesis services, including Stapled Peptides, Cyclization at side chain, Head-to-tail cyclization, etc.",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":236,"parentId":219,"title":237,"subTitle":78,"excerpt":238,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"sort":8,"hotState":5,"newState":5,"type":50,"customerTestimonials":8,"productCatalog":8,"relatedTitles":8,"productService":8,"customerTestimonialsList":8,"relatedTitlesList":8,"serviceFeatureSubList":8,"productCatalogList":8},45,"Glycopeptides","GenCefe Biotech provides glycosylation modification services, producing glycopeptides with N-linked and O-linked types to enhance protein stability, activity, and cell signaling.",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":240,"parentId":219,"title":241,"subTitle":78,"excerpt":242,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"sort":8,"hotState":5,"newState":5,"type":50,"customerTestimonials":8,"productCatalog":8,"relatedTitles":8,"productService":8,"customerTestimonialsList":8,"relatedTitlesList":8,"serviceFeatureSubList":8,"productCatalogList":8},46,"Peptide Libraries","GenCefe Biotech provides a variety of peptide library synthesis services, including over lapping libraries, random libraries, amino acid scanning libraries, etc.",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":244,"parentId":219,"title":245,"subTitle":78,"excerpt":246,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"sort":8,"hotState":5,"newState":5,"type":93,"customerTestimonials":8,"productCatalog":8,"relatedTitles":8,"productService":8,"customerTestimonialsList":8,"relatedTitlesList":8,"serviceFeatureSubList":8,"productCatalogList":8},47,"Catalog Peptides","GenCefe Biotech offers over 2,000 catalog peptides covering popular research areas, available from stock.",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":248,"title":249,"excerpt":8,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"sort":8,"createDate":8,"secondColor":8,"showOrderPic":8,"homeState":8,"homePic":8,"homeTitle":8,"homeDesc":8,"homeSort":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"serviceFeatureList":8,"productServiceSubList":250},4,"Synthetic DNA Libraries",[251,255,259,263,267],{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":252,"parentId":248,"title":253,"subTitle":78,"excerpt":254,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"sort":8,"hotState":5,"newState":5,"type":50,"customerTestimonials":8,"productCatalog":8,"relatedTitles":8,"productService":8,"customerTestimonialsList":8,"relatedTitlesList":8,"serviceFeatureSubList":8,"productCatalogList":8},30,"Site-Directed Mutagenesis Libraries","Site-directed mutagenesis libraries introduce defined amino acid substitutions at selected positions, enabling structure–function studies, protein engineering, and antibody optimization.",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":256,"parentId":248,"title":257,"subTitle":78,"excerpt":258,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"sort":8,"hotState":5,"newState":5,"type":50,"customerTestimonials":8,"productCatalog":8,"relatedTitles":8,"productService":8,"customerTestimonialsList":8,"relatedTitlesList":8,"serviceFeatureSubList":8,"productCatalogList":8},21,"Random Mutagenesis Libraries","Random mutagenesis libraries generate diverse sequence variants through random nucleotide mutations, making them ideal for directed evolution and functional discovery.",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":260,"parentId":248,"title":261,"subTitle":78,"excerpt":262,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"sort":8,"hotState":5,"newState":5,"type":50,"customerTestimonials":8,"productCatalog":8,"relatedTitles":8,"productService":8,"customerTestimonialsList":8,"relatedTitlesList":8,"serviceFeatureSubList":8,"productCatalogList":8},31,"Degenerate (Saturation Mutagenesis) Libraries","Degenerate (saturation mutagenesis) libraries introduce NNK or NNN codons at selected positions to generate broad amino acid diversity for protein engineering and affinity maturation.",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":264,"parentId":248,"title":265,"subTitle":78,"excerpt":266,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"sort":8,"hotState":5,"newState":5,"type":50,"customerTestimonials":8,"productCatalog":8,"relatedTitles":8,"productService":8,"customerTestimonialsList":8,"relatedTitlesList":8,"serviceFeatureSubList":8,"productCatalogList":8},32,"Controlled (Trimer) Libraries","Controlled (Trimer) libraries use predefined trinucleotide building blocks to precisely control amino acid diversity while reducing codon redundancy for efficient library design.",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":268,"parentId":248,"title":269,"subTitle":78,"excerpt":270,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"sort":8,"hotState":5,"newState":5,"type":50,"customerTestimonials":8,"productCatalog":8,"relatedTitles":8,"productService":8,"customerTestimonialsList":8,"relatedTitlesList":8,"serviceFeatureSubList":8,"productCatalogList":8},33,"CRISPR sgRNA Libraries ","CRISPR sgRNA libraries enable high-throughput functional screening for target discovery, functional genomics, and phenotype-based studies.",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":272,"title":273,"excerpt":8,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"sort":8,"createDate":8,"secondColor":8,"showOrderPic":8,"homeState":8,"homePic":8,"homeTitle":8,"homeDesc":8,"homeSort":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"serviceFeatureList":8,"productServiceSubList":274},8,"Reagents & Kits",[],{"msg":4,"code":5,"data":276},{"companyName":277,"shortCompanyName":278,"title":278,"subTitle":279,"siteUrl":280,"siteDescription":281,"siteKeywords":282,"beiAnInfo":283,"email":284,"phone":285,"address":286},"GENCEFE Biotech (Wuxi, China) ","GenCefe","Your Reliable Partner of Oligo, Gene, Peptide, Protein ","https:\u002F\u002Fwww.gencefebio.com\u002F","GenCefe specializes in DNA, RNA, gene, peptide, and protein synthesis. Combined with our advanced AI-assisted design platform, we provide high-quality services for synthetic biology, molecular diagnostics, and drug discovery.","gene synthesis, oligo synthesis, RNA synthesis, DNA synthesis, peptide synthesis, protein expression and purification, gencefe, gencefe biotech","ICP备案：XXXXXXX\r\n苏公网安备32021402001785号","gene@gencefebio.com","+1 408-828-0438","17800 Castleton St, Ste 665, City of industry, CA 91748, USA",{"msg":4,"code":5,"data":288},{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":289,"categoryName":186,"title":290,"imgUrl":291,"content":292,"excerpt":78,"publishDate":293,"seoTitle":294,"seoDesc":295,"seoKeywords":296,"createDate":297,"sort":219,"relatedPostIds":298,"firstServiceProductId":185,"secondServiceProductIds":299,"relatedPost":300,"productService":356,"allSecondProductService":366,"twoSecondProductService":369},152,"Optimizing Antibody Yield and Stability in Recombinant Production","http:\u002F\u002Fmanage.gencefebio.com\u002Fprofile\u002Fupload\u002F2026\u002F07\u002F06\u002F07_20260706150020A289.png","\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">\u003Cimg src=\"http:\u002F\u002Fmanage.gencefebio.com\u002Fprofile\u002Fupload\u002F2026\u002F07\u002F06\u002F07_20260706150026A290.png\" title=\"antibody stability, codon optimization\" alt=\"antibody stability, codon optimization\" width=\"100%\"\u002F>\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Recombinant antibody production is a complex process influenced by genetic design, host cell characteristics, culture conditions, and downstream processing. Achieving high yield and long-term stability is critical for research applications, diagnostic assays, and therapeutic development. Optimizing these parameters ensures not only efficient production but also reproducible performance across batches. With careful design and systematic workflow, recombinant antibodies can meet stringent quality requirements while maintaining structural integrity and functional activity.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cstrong>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Codon Optimization and Gene Design\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">The DNA sequence encoding an antibody greatly impacts expression efficiency. Codon usage differs across species, and mismatched codons can slow translation and reduce protein yield. By performing codon optimization for the chosen expression host—whether HEK293, CHO, or other mammalian systems—translation efficiency is maximized. Additionally, sequence engineering can reduce mRNA secondary structures, eliminate cryptic splice sites, and remove repetitive motifs that may hinder expression. Careful gene design thus lays the foundation for both high yield and functional stability.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cstrong>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Selection of Expression Host and Culture Conditions\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">The choice of host cells is a key determinant of antibody production and stability. HEK293 cells are often preferred for rapid, small-scale research production due to high transfection efficiency and fast expression. CHO cells, in contrast, provide robust growth, high-density culture capability, and consistent protein glycosylation, making them ideal for preclinical and commercial-scale production. Optimizing culture conditions—such as media composition, temperature shifts, feeding strategies, and bioreactor parameters—can further enhance yield and promote proper protein folding, reducing aggregation and misfolding.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cstrong>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Protein Folding and Quality Control\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Proper folding is essential for antibody activity and stability. Misfolded proteins can aggregate or lose binding specificity, compromising both research results and therapeutic applications. Mammalian expression systems provide essential post-translational modifications, disulfide bond formation, and chaperone-assisted folding. Monitoring folding efficiency through analytical techniques such as size-exclusion chromatography, SDS-PAGE, and mass spectrometry ensures that only correctly folded antibodies proceed to purification, preserving functional activity and reducing batch variability.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cstrong>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Purification Strategies for Stability\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Downstream purification is another critical factor affecting antibody stability. Affinity chromatography, particularly Protein A\u002FG capture, enables high-purity recovery while maintaining native conformation. Polishing steps such as ion-exchange and size-exclusion chromatography remove aggregates, host-cell proteins, and residual nucleic acids. Formulation choices—including pH, buffer composition, and stabilizing excipients—further enhance long-term stability, ensuring antibodies remain active during storage and shipment.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cstrong>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Enhancing Thermal and Storage Stability\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Thermal stability directly affects both shelf life and functional performance. Introducing stabilizing mutations, optimizing buffer conditions, and controlling storage temperature are common strategies to extend stability. Lyophilization or inclusion of cryoprotectants can further preserve antibody structure, particularly for long-term storage or transport under variable conditions. These measures are especially important for diagnostic reagents, research antibodies shipped internationally, and therapeutic candidates that require extended shelf life.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cstrong>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Scaling Up Without Compromising Quality\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Scale-up introduces new challenges in yield and stability. Maintaining consistent culture conditions, minimizing shear stress in bioreactors, and carefully monitoring bioprocess parameters are essential for large-scale production. Recombinant antibody platforms allow predictable scale-up because the underlying gene sequence is constant and expression conditions are well-characterized. This reproducibility ensures that antibodies retain activity and stability across different production scales, from milliliters to liters.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Optimizing recombinant antibody yield and stability requires an integrated approach spanning gene design, host selection, culture optimization, protein folding, purification, and formulation. By carefully managing these parameters, researchers and developers can produce antibodies that are both high-yielding and structurally robust, supporting applications in research, diagnostics, and therapeutics. Recombinant production platforms provide the necessary control and flexibility to achieve these goals efficiently.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Led by an experienced team of recombinant antibody and protein scientists, GenCefe Biotech provides comprehensive solutions for \u003C\u002Fspan>\u003Ca href=\"https:\u002F\u002Fwww.gencefebio.com\u002FproductsAndservices\u002F10-Recombinant_Antibody.html\" style=\"text-decoration: underline; font-family: Montserrat; font-size: 16px; color: rgb(79, 129, 189);\">\u003Cspan style=\"font-family: Montserrat; font-size: 16px; color: rgb(79, 129, 189);\">recombinant antibody and protein production\u003C\u002Fspan>\u003C\u002Fa>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">. Supported by our well-established \u003C\u002Fspan>\u003Ca href=\"https:\u002F\u002Fwww.gencefebio.com\u002FproductsAndservices\u002F9-Gene_Synthesis_and_Related_Services.html\" style=\"text-decoration: underline; font-family: Montserrat; font-size: 16px; color: rgb(79, 129, 189);\">\u003Cspan style=\"font-family: Montserrat; font-size: 16px; color: rgb(79, 129, 189);\">gene synthesis\u003C\u002Fspan>\u003C\u002Fa>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\"> platform and advanced CHO and HEK293 mammalian expression systems, we deliver end-to-end services—from gene synthesis and expression vector construction to \u003C\u002Fspan>\u003Ca href=\"https:\u002F\u002Fwww.gencefebio.com\u002FproductsAndservices\u002F10-Recombinant_Antibody.html\" style=\"text-decoration: underline; font-family: Montserrat; font-size: 16px; color: rgb(79, 129, 189);\">\u003Cspan style=\"font-family: Montserrat; font-size: 16px; color: rgb(79, 129, 189);\">antibody and protein purification\u003C\u002Fspan>\u003C\u002Fa>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">, as well as large-scale manufacturing.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr\u002F>\u003C\u002Fp>","2026-01-27 00:00:00","Optimizing Recombinant Antibody Yield and Stability: Strategies for High-Quality Production | GenCefe Biotech","Learn key strategies to optimize yield and stability of recombinant antibodies, including codon optimization, host selection, culture conditions, and purification techniques.","recombinant antibody yield, antibody stability, codon optimization, expression host selection, mammalian expression, protein folding, GenCefe Biotech","2026-01-27 15:44:24","154,153,151,150,149","72,73",[301,312,323,334,345],{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":302,"categoryName":186,"title":303,"imgUrl":304,"content":305,"excerpt":78,"publishDate":306,"seoTitle":307,"seoDesc":308,"seoKeywords":309,"createDate":310,"sort":248,"relatedPostIds":311,"firstServiceProductId":185,"secondServiceProductIds":299,"relatedPost":8,"productService":8,"allSecondProductService":8,"twoSecondProductService":8},149,"Fc Engineering: Applications and Trends in Antibody Drug Development","http:\u002F\u002Fmanage.gencefebio.com\u002Fprofile\u002Fupload\u002F2026\u002F07\u002F06\u002F04_20260706145835A283.png","\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">\u003Cimg src=\"http:\u002F\u002Fmanage.gencefebio.com\u002Fprofile\u002Fupload\u002F2026\u002F07\u002F06\u002F04_20260706145840A284.png\" title=\"antibody drug development\" alt=\"antibody drug development\" width=\"100%\"\u002F>\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Fc engineering has become an essential pillar in the evolution of antibody therapeutics. As antibody drugs mature beyond simple target binding, the Fc region—once considered merely a structural backbone—has emerged as a powerful design element capable of modulating immune response, pharmacokinetics, tissue distribution, and overall therapeutic behavior. Modern biologics rely not only on the antigen-binding domain but also on the refined functions of the Fc region to achieve enhanced efficacy and safety. As the biopharmaceutical industry moves toward next-generation antibody formats, Fc engineering is reshaping how antibodies are optimized for oncology, autoimmune diseases, infectious diseases, and beyond.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cstrong>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Understanding the Role of the Fc Region\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">The Fc region is responsible for mediating interactions between antibodies and various immune components, including Fcγ receptors, complement proteins, and neonatal Fc receptors (FcRn). These interactions determine whether an antibody primarily triggers cytotoxic immune responses, enhances phagocytosis, or prolongs its presence in circulation. Because each therapeutic antibody may require a specific balance between effector functions and half-life, manipulating the Fc region has become an indispensable strategy for designing precisely tuned biologics.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">In oncology, for example, strong effector functions such as antibody-dependent cellular cytotoxicity (ADCC) or complement-dependent cytotoxicity (CDC) are desirable. In contrast, for inflammatory or autoimmune diseases, the optimal therapeutic effect often requires minimizing immune activation to avoid exacerbating disease progression. Understanding these functional contexts is foundational for selecting an Fc engineering strategy.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cstrong>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Enhancing Effector Functions for Targeted Cytotoxicity\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">One of the most widely adopted uses of Fc engineering is enhancing the antibody’s ability to recruit immune cells to eliminate pathogenic targets. By altering Fcγ receptor binding affinities through amino acid substitutions or glyco-engineering, developers can significantly increase ADCC and CDC potency.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">An important example is the optimization of Fc glycan structures. Removing fucose residues (afucosylation) can dramatically improve an antibody’s interaction with FcγRIIIa receptors, resulting in stronger NK-cell–mediated cytotoxic responses. This approach has led to the development of several clinically approved antibodies demonstrating higher tumor-killing efficiency compared with their non-engineered counterparts.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">These engineered enhancements have expanded the potential of monoclonal antibodies in cancer immunotherapy, allowing more precise and powerful targeting of tumor cells without increasing systemic toxicity.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cstrong>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Suppressing Immune Activation for Autoimmune and Chronic Diseases\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">While strengthening immune activation is valuable in oncology, certain therapeutic areas require the opposite outcome. For autoimmune diseases, chronic inflammation, or enzyme replacement therapy, it’s often necessary to reduce effector functions to prevent unintended tissue damage.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">To address this requirement, Fc silencing mutations have been developed to diminish binding to Fcγ receptors and eliminate complement recruitment. By eliminating these interactions, engineered antibodies retain target affinity but minimize immune-mediated side effects. These modifications have directly contributed to the improved tolerability and safety of biologics targeting inflammatory pathways, making them suitable for long-term treatment regimens.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cstrong>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Improving Pharmacokinetics Through FcRn Optimization\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Beyond immune effector regulation, Fc engineering is a powerful method for modulating antibody half-life. Through interactions with FcRn receptors, antibodies can be recycled instead of being degraded, allowing them to remain in circulation for weeks. Consequently, introducing engineered mutations that enhance FcRn binding at acidic pH is a proven way to prolong half-life and reduce dosing frequency.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Such modifications have set new standards for patient compliance by enabling monthly or even quarterly dosing intervals for chronic conditions. As more therapeutics aim for self-administration and long-acting formulations, FcRn-enhancing mutations are becoming increasingly prevalent in drug development pipelines.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cstrong>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Fc Engineering in Emerging Antibody Formats\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Fc engineering is now integrated into many advanced therapeutic platforms, including bispecific antibodies, antibody–drug conjugates (ADCs), and therapeutic fusion proteins. In bispecific formats, Fc modifications help stabilize the molecule, balance arm pairing, and fine-tune immune activation. For ADCs, an optimized Fc region ensures better pharmacokinetics and more reliable trafficking to target tissues.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">With the advancement of AI-assisted protein design and high-throughput screening, Fc engineering is also evolving toward more predictive, data-driven strategies. Machine learning models are increasingly used to identify mutation combinations that enhance stability or modulate immune interactions, accelerating development timelines and increasing success rates.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cstrong>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Future Trends in Fc Engineering\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Research continues to push the boundaries of what the Fc region can achieve. Novel directions include Fc variants designed to localize antibodies to specific tissues, Fc switches that respond to physiological cues, and immune-modulating designs that create more selective or context-dependent effector functions. These emerging technologies reflect a broader shift toward highly customizable antibody platforms, where each functional aspect can be tuned to meet the needs of precision medicine.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">As regulatory agencies and industry stakeholders gain more experience with engineered Fc designs, the adoption of these innovations is expected to accelerate, shaping the next generation of safer, more effective, and more versatile therapeutic antibodies.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Led by an experienced team of recombinant antibody and protein scientists, GenCefe Biotech provides comprehensive solutions for \u003C\u002Fspan>\u003Ca href=\"https:\u002F\u002Fwww.gencefebio.com\u002FproductsAndservices\u002F10-Recombinant_Antibody.html\" style=\"text-decoration: underline; font-family: Montserrat; font-size: 16px; color: rgb(79, 129, 189);\">\u003Cspan style=\"font-family: Montserrat; font-size: 16px; color: rgb(79, 129, 189);\">recombinant antibody and protein production\u003C\u002Fspan>\u003C\u002Fa>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">. Supported by our well-established \u003C\u002Fspan>\u003Ca href=\"https:\u002F\u002Fwww.gencefebio.com\u002FproductsAndservices\u002F9-Gene_Synthesis_and_Related_Services.html\" style=\"text-decoration: underline; font-family: Montserrat; font-size: 16px; color: rgb(79, 129, 189);\">\u003Cspan style=\"font-family: Montserrat; font-size: 16px; color: rgb(79, 129, 189);\">gene synthesis\u003C\u002Fspan>\u003C\u002Fa>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\"> platform and advanced CHO and HEK293 mammalian expression systems, we deliver end-to-end services—from gene synthesis and expression vector construction to \u003C\u002Fspan>\u003Ca href=\"https:\u002F\u002Fwww.gencefebio.com\u002FproductsAndservices\u002F10-Recombinant_Antibody.html\" style=\"text-decoration: underline; font-family: Montserrat; font-size: 16px; color: rgb(79, 129, 189);\">\u003Cspan style=\"font-family: Montserrat; font-size: 16px; color: rgb(79, 129, 189);\">antibody and protein purification\u003C\u002Fspan>\u003C\u002Fa>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">, as well as large-scale manufacturing.\u003C\u002Fspan>\u003C\u002Fp>","2026-01-06 00:00:00","Fc Engineering in Antibody Drug Development: Mechanisms, Applications, and Future Trends | GenCefe Biotech","Learn how Fc engineering enhances antibody efficacy, stability, and therapeutic performance, and explore current technologies and trends shaping next-generation antibody therapeutics.","Fc engineering, antibody drug development, Fc region modification, ADCC, CDC, half-life extension, recombinant antibodies, GenCefe Biotech","2026-01-06 14:53:05","156,155,154,152,147",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":313,"categoryName":186,"title":314,"imgUrl":315,"content":316,"excerpt":78,"publishDate":317,"seoTitle":318,"seoDesc":319,"seoKeywords":320,"createDate":321,"sort":195,"relatedPostIds":322,"firstServiceProductId":185,"secondServiceProductIds":299,"relatedPost":8,"productService":8,"allSecondProductService":8,"twoSecondProductService":8},150," Recombinant Antibodies for Diagnostics: Ensuring Consistency and Lot-to-Lot Reproducibility ","http:\u002F\u002Fmanage.gencefebio.com\u002Fprofile\u002Fupload\u002F2026\u002F07\u002F06\u002F05_20260706145917A285.png","\u003Cp style=\"text-wrap-mode: wrap;\">\u003Cspan style=\"font-family: Montserrat;\">\u003Cimg src=\"http:\u002F\u002Fmanage.gencefebio.com\u002Fprofile\u002Fupload\u002F2026\u002F07\u002F06\u002F05_20260706145922A286.png\" title=\"diagnostic antibodies, assay reproducibility,\" alt=\"diagnostic antibodies, assay reproducibility,\" width=\"100%\"\u002F>\u003C\u002Fspan>\u003C\u002Fp>\u003Cp style=\"text-wrap-mode: wrap;\">\u003Cspan style=\"font-family: Montserrat;\">Diagnostic technologies rely heavily on the precision and consistency of antibodies. Whether for immunoassays, lateral-flow tests, biomarker quantification, or clinical screening, the ability of an antibody to bind reliably and reproducibly across batches is a foundational requirement. Traditional hybridoma-derived antibodies, while widely used, inherently carry biological variability that can compromise assay performance over time. Recombinant antibodies, produced through sequence-defined expression systems, have emerged as the gold standard for assays that demand long-term stability and consistency. As diagnostic markets expand and regulatory expectations increase, the advantages offered by recombinant technologies are becoming indispensable.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp style=\"text-wrap-mode: wrap;\">\u003Cspan style=\"font-family: Montserrat;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp style=\"text-wrap-mode: wrap;\">\u003Cstrong>\u003Cspan style=\"font-family: Montserrat;\">The Limitations of Hybridoma-Derived Antibodies\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp style=\"text-wrap-mode: wrap;\">\u003Cspan style=\"font-family: Montserrat;\">Hybridoma technology has contributed significantly to antibody research and product development, but its biological nature introduces unpredictability. Hybridoma cells may drift genetically or lose productivity over time, resulting in significant variation between production lots. Even subtle differences in glycosylation, sequence stability, or cell viability can translate into reduced binding affinity, altered specificity, or increased background noise in diagnostic assays. Such inconsistencies become particularly problematic in high-throughput clinical diagnostics, where precision and standardization are essential for reliable decision-making. As global regulatory frameworks tighten around assay reproducibility, reliance on unstable hybridoma lines poses increasing challenges.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp style=\"text-wrap-mode: wrap;\">\u003Cspan style=\"font-family: Montserrat;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp style=\"text-wrap-mode: wrap;\">\u003Cstrong>\u003Cspan style=\"font-family: Montserrat;\">How Recombinant Antibodies Address Variability\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp style=\"text-wrap-mode: wrap;\">\u003Cspan style=\"font-family: Montserrat;\">Recombinant antibodies overcome these limitations by anchoring production to a defined DNA sequence rather than a biologically unstable cell line. Once the sequence is identified, cloned, and validated, the antibody can be produced consistently in mammalian, bacterial, or cell-free systems with minimal variability. The expression host, culture conditions, and purification procedures can be standardized and reproduced across batches and facilities. This sequence-based control ensures that diagnostic developers receive identical molecules every time, regardless of scale or timing, eliminating the risk of genetic drift or spontaneous mutation. Such reproducibility significantly enhances product reliability and reduces batch-to-batch troubleshooting.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp style=\"text-wrap-mode: wrap;\">\u003Cspan style=\"font-family: Montserrat;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp style=\"text-wrap-mode: wrap;\">\u003Cstrong>\u003Cspan style=\"font-family: Montserrat;\">Stability and Long-Term Supply Assurance\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp style=\"text-wrap-mode: wrap;\">\u003Cspan style=\"font-family: Montserrat;\">Many diagnostic assays require stable supply over multiple years, especially when incorporated into commercial diagnostic kits, regulatory submissions, or mass-market clinical tests. A single change in antibody characteristics can necessitate re-validation, leading to costly delays and compliance risks. Recombinant antibody technology directly addresses this concern by enabling unlimited production from a preserved DNA sequence stored under secure and stable conditions. This guarantees continuity of supply even if production facilities change or bioreactors are upgraded. Long-term storage of expression constructs also allows rapid scale-up, ensuring that increasing market demand does not compromise batch uniformity or timeline reliability.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp style=\"text-wrap-mode: wrap;\">\u003Cspan style=\"font-family: Montserrat;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp style=\"text-wrap-mode: wrap;\">\u003Cstrong>\u003Cspan style=\"font-family: Montserrat;\">Enhanced Specificity Through Sequence Engineering\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp style=\"text-wrap-mode: wrap;\">\u003Cspan style=\"font-family: Montserrat;\">Recombinant antibody platforms also provide the opportunity to refine specificity and affinity through rational sequence engineering. Developers can eliminate cross-reactivity, reduce non-specific binding, or enhance performance under specific assay conditions such as pH constraints or high-salt environments. These improvements are difficult to achieve through hybridoma methods, where antibody optimization relies on biological unpredictability. By contrast, recombinant engineering allows precise control over variable regions, constant regions, and framework stability. The result is a highly tailored molecule that performs consistently in clinical assays, even under stress or in complex matrices such as serum, plasma, or whole blood.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp style=\"text-wrap-mode: wrap;\">\u003Cspan style=\"font-family: Montserrat;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp style=\"text-wrap-mode: wrap;\">\u003Cstrong>\u003Cspan style=\"font-family: Montserrat;\">Regulatory Advantages and Quality Control\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp style=\"text-wrap-mode: wrap;\">\u003Cspan style=\"font-family: Montserrat;\">As diagnostic products face increasingly rigorous global regulatory standards, recombinant antibodies offer clear advantages in traceability, documentation, and quality assurance. Because production is sequence-defined, each batch can be validated and documented with precise molecular identity. Regulatory agencies favor such predictability, particularly in assays designed for infectious disease detection, oncology screening, and chronic disease monitoring. Consistent molecular profiles also support manufacturing audits, reduce batch-failure rates, and streamline quality control processes. For companies developing diagnostic assays intended for international markets, recombinant systems provide a robust and compliant pathway to scale.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp style=\"text-wrap-mode: wrap;\">\u003Cspan style=\"font-family: Montserrat;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp style=\"text-wrap-mode: wrap;\">\u003Cstrong>\u003Cspan style=\"font-family: Montserrat;\">Future Outlook: Recombinant Antibodies as the New Diagnostic Standard\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp style=\"text-wrap-mode: wrap;\">\u003Cspan style=\"font-family: Montserrat;\">As the diagnostic industry continues to grow, the requirement for long-term reproducibility and global standardization is becoming more critical. Recombinant antibodies are positioned to become the default option for IVD manufacturers, clinical laboratories, and biotech companies seeking dependable and scalable solutions. With advances in sequence optimization, high-throughput screening, and AI-guided antibody engineering, the next wave of diagnostic reagents will increasingly rely on recombinant production. This shift promises a more reliable and sustainable diagnostic ecosystem, enabling faster innovation and more precise clinical decision-making.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp style=\"text-wrap-mode: wrap;\">\u003Cspan style=\"font-family: Montserrat;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp style=\"text-wrap-mode: wrap;\">\u003Cspan style=\"font-family: Montserrat;\">Led by an experienced team of recombinant antibody and protein scientists, GenCefe Biotech provides comprehensive solutions for \u003C\u002Fspan>\u003Ca href=\"https:\u002F\u002Fwww.gencefebio.com\u002FproductsAndservices\u002F10-Recombinant_Antibody.html\" style=\"font-family: Montserrat; color: rgb(79, 129, 189);\">recombinant antibody and protein production\u003C\u002Fa>\u003Cspan style=\"font-family: Montserrat;\">. Supported by our well-established \u003C\u002Fspan>\u003Ca href=\"https:\u002F\u002Fwww.gencefebio.com\u002FproductsAndservices\u002F9-Gene_Synthesis_and_Related_Services.html\" style=\"font-family: Montserrat; color: rgb(79, 129, 189);\">gene synthesis\u003C\u002Fa>\u003Cspan style=\"font-family: Montserrat;\"> platform and advanced CHO and HEK293 mammalian expression systems, we deliver end-to-end services—from gene synthesis and expression vector construction to \u003C\u002Fspan>\u003Ca href=\"https:\u002F\u002Fwww.gencefebio.com\u002FproductsAndservices\u002F10-Recombinant_Antibody.html\" style=\"font-family: Montserrat; color: rgb(79, 129, 189);\">antibody and protein purification\u003C\u002Fa>\u003Cspan style=\"font-family: Montserrat;\">, as well as large-scale manufacturing.\u003C\u002Fspan>\u003C\u002Fp>","2026-01-13 00:00:00","Recombinant Antibodies for Diagnostics: Reliability, Consistency, and Lot-to-Lot Stability | GenCefe Biotech","Discover why recombinant antibodies deliver superior consistency, stability, and reproducibility in diagnostic assay development compared to hybridoma-derived antibodies.","recombinant antibodies, diagnostic antibodies, assay reproducibility, lot-to-lot consistency, antibody stability, diagnostics development, GenCefe Biotech","2026-01-13 10:39:00","154,152,149,148,146",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":324,"categoryName":186,"title":325,"imgUrl":326,"content":327,"excerpt":78,"publishDate":328,"seoTitle":329,"seoDesc":330,"seoKeywords":331,"createDate":332,"sort":170,"relatedPostIds":333,"firstServiceProductId":185,"secondServiceProductIds":299,"relatedPost":8,"productService":8,"allSecondProductService":8,"twoSecondProductService":8},151,"HEK293 vs. CHO: Choosing the Optimal Mammalian System for Recombinant Antibody Expression","http:\u002F\u002Fmanage.gencefebio.com\u002Fprofile\u002Fupload\u002F2026\u002F07\u002F06\u002F06_20260706145948A287.png","\u003Cp>\u003Cspan style=\"font-family: Montserrat;\">\u003Cimg src=\"http:\u002F\u002Fmanage.gencefebio.com\u002Fprofile\u002Fupload\u002F2026\u002F07\u002F06\u002F06_20260706145953A288.png\" title=\"CHO expression, recombinant antibody production\" alt=\"CHO expression, recombinant antibody production\" width=\"100%\"\u002F>\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat;\">Mammalian expression systems play a central role in the development of recombinant antibodies, offering the complex folding and post-translational modifications required for biologically active molecules. Among all mammalian platforms, HEK293 and CHO cell lines remain the two most widely used systems for research, diagnostics, and therapeutic development. While both are capable of producing functional antibodies, they differ significantly in productivity, stability, glycosylation patterns, scalability, and suitability for commercial manufacturing. Selecting the right system is essential for meeting project goals, controlling costs, and ensuring long-term feasibility. This article examines the strengths and limitations of HEK293 and CHO systems, helping researchers identify which platform best aligns with their scientific and development needs.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cstrong>\u003Cspan style=\"font-family: Montserrat;\">The Profile of HEK293 Expression Systems\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat;\">HEK293 cells are human embryonic kidney–derived lines known for their high transfection efficiency and rapid protein expression. These properties make HEK293 ideal for early-stage research where speed and flexibility are priorities. Researchers often rely on HEK293 for transient expression during antibody screening, variant comparison, or functional validation because the system can deliver high yields within a short production cycle.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat;\">Human-origin glycosylation gives HEK293-expressed antibodies structural features closer to human physiological forms. In certain applications such as receptor interaction studies or preclinical assays requiring native-like glycan profiles, this advantage contributes to more biologically relevant results. However, the same glycosylation characteristics may introduce variability or regulatory concerns in therapeutic development, as human cell lines can carry endogenous viral sequences or complex glycan structures that must undergo additional safety evaluation.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat;\">Another consideration is scalability. While HEK293 cells adapt well to suspension culture, they typically have higher metabolic burden and lower long-term stability compared with CHO cells. These characteristics limit their suitability for large-volume, industrial-scale manufacturing, though they remain extremely valuable for rapid expression and research-grade antibody production.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cstrong>\u003Cspan style=\"font-family: Montserrat;\">The Profile of CHO Expression Systems\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat;\">CHO cells have become the dominant platform for commercial antibody manufacturing, and for good reason. Their robustness, adaptability, and genetic stability enable high-density cell growth and consistent protein production. CHO cells thrive in chemically defined, serum-free media, allowing efficient scale-up in bioreactors ranging from laboratory volumes to thousands of liters.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat;\">The glycosylation pattern of CHO-derived proteins is well-characterized and is widely accepted by global regulatory agencies due to extensive historical safety data. Therapeutic antibodies produced in CHO systems typically exhibit predictable pharmacokinetics, low immunogenic risk, and consistent structural quality. These advantages have led to CHO becoming the backbone of therapeutic antibody manufacturing pipelines and biopharmaceutical commercialization.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat;\">CHO cells also offer strong flexibility for both transient expression and stable cell-line development. Stable CHO lines, in particular, provide exceptional reproducibility and high productivity, enabling sustainable long-term supply of clinical- and commercial-grade antibodies. This capability has solidified CHO's position as the industry standard for biologics manufacturing.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cstrong>\u003Cspan style=\"font-family: Montserrat;\">Glycosylation Differences and Their Functional Implications\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat;\">Glycosylation is a critical factor affecting antibody stability, half-life, binding affinity, and effector function. HEK293 cells generate human-like glycan structures, which can be beneficial for certain functional assays but may also include glycoforms that require additional safety consideration for therapeutic applications.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat;\">CHO cells produce non-human glycan structures; however, these patterns are well-studied and have proven to be safe and reliable in the clinical context. CHO-derived glycans also support optimized effector functions such as ADCC and CDC when needed. Thanks to well-established glycoengineering tools, CHO systems can now be tailored to achieve desired glycan profiles with high precision.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cstrong>\u003Cspan style=\"font-family: Montserrat;\">Expression Yield and Productivity\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat;\">While HEK293 excels in rapid transient expression, CHO generally offers higher overall productivity, especially in stable cell-line systems. Industrial CHO cultures routinely reach high titers, making them more cost-effective for medium to large-scale antibody production. HEK293 productivity is often sufficient for research use, but CHO provides superior long-term output for manufacturing programs.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat;\">\u003Cbr\u002F>\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cstrong>\u003Cspan style=\"font-family: Montserrat;\">Which System Should You Choose?\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat;\">The decision between HEK293 and CHO ultimately depends on project goals. HEK293 is excellent for rapid prototyping, early antibody characterization, and applications requiring human-like glycosylation. CHO is unmatched for large-scale production, regulatory compliance, and commercial viability. Many development pipelines strategically use both: HEK293 for early research and CHO for preclinical and clinical manufacturing. Understanding the strengths of each system ensures efficient planning and reduces downstream development risks.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat;\">Led by an experienced team of recombinant antibody and protein scientists, GenCefe Biotech provides comprehensive solutions for \u003C\u002Fspan>\u003Ca href=\"https:\u002F\u002Fwww.gencefebio.com\u002FproductsAndservices\u002F10-Recombinant_Antibody.html\" style=\"text-decoration: underline; font-family: Montserrat; color: rgb(79, 129, 189);\">\u003Cspan style=\"font-family: Montserrat; color: rgb(79, 129, 189);\">recombinant antibody and protein production\u003C\u002Fspan>\u003C\u002Fa>\u003Cspan style=\"font-family: Montserrat;\">. Supported by our well-established \u003C\u002Fspan>\u003Ca href=\"https:\u002F\u002Fwww.gencefebio.com\u002FproductsAndservices\u002F9-Gene_Synthesis_and_Related_Services.html\" style=\"text-decoration: underline; font-family: Montserrat; color: rgb(79, 129, 189);\">\u003Cspan style=\"font-family: Montserrat; color: rgb(79, 129, 189);\">gene synthesis\u003C\u002Fspan>\u003C\u002Fa>\u003Cspan style=\"font-family: Montserrat;\"> platform and advanced CHO and HEK293 mammalian expression systems, we deliver end-to-end services—from gene synthesis and expression vector construction to \u003C\u002Fspan>\u003Ca href=\"https:\u002F\u002Fwww.gencefebio.com\u002FproductsAndservices\u002F10-Recombinant_Antibody.html\" style=\"text-decoration: underline; font-family: Montserrat; color: rgb(79, 129, 189);\">\u003Cspan style=\"font-family: Montserrat; color: rgb(79, 129, 189);\">antibody and protein purification\u003C\u002Fspan>\u003C\u002Fa>\u003Cspan style=\"font-family: Montserrat;\">, as well as large-scale manufacturing.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr\u002F>\u003C\u002Fp>","2026-01-20 00:00:00","HEK293 vs. CHO for Recombinant Antibody Production: Key Differences, Advantages, and Selection Guide | GenCefe Biotech","Compare HEK293 and CHO expression systems for recombinant antibody production. Learn how productivity, glycosylation, scalability, and stability differ between these two major mammalian platforms.","HEK293 expression, CHO expression, recombinant antibody production, mammalian expression system, glycosylation, antibody development, GenCefe Biotech","2026-01-20 16:14:06","157,155,154,150,147",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":335,"categoryName":186,"title":336,"imgUrl":337,"content":338,"excerpt":78,"publishDate":339,"seoTitle":340,"seoDesc":341,"seoKeywords":342,"createDate":343,"sort":272,"relatedPostIds":344,"firstServiceProductId":185,"secondServiceProductIds":299,"relatedPost":8,"productService":8,"allSecondProductService":8,"twoSecondProductService":8},153,"Antibody Humanization: Strategies and Benefits for Therapeutic Development ","http:\u002F\u002Fmanage.gencefebio.com\u002Fprofile\u002Fupload\u002F2026\u002F07\u002F06\u002F08_20260706150059A291.jpg","\u003Cp>\u003Cspan style=\"font-family: Montserrat;\">\u003Cimg src=\"http:\u002F\u002Fmanage.gencefebio.com\u002Fprofile\u002Fupload\u002F2026\u002F07\u002F06\u002F08_20260706150105A292.jpg\" title=\" therapeutic antibodies, reduced immunogenicity, \" alt=\" therapeutic antibodies, reduced immunogenicity, \" width=\"100%\"\u002F>\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat;\">Antibody humanization is a critical step in therapeutic antibody development, aimed at reducing immunogenicity while preserving binding affinity and specificity. Non-human antibodies, such as murine or rabbit-derived monoclonals, are highly effective for research but can provoke immune responses in patients if used directly as therapeutics. Humanization techniques modify these antibodies to resemble human immunoglobulins while retaining their original antigen recognition, balancing safety and efficacy for clinical use.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat;\">Humanization has become standard practice in the development of monoclonal antibodies for oncology, autoimmune disorders, infectious diseases, and other therapeutic areas. By understanding the strategies and benefits of humanization, developers can design antibodies that are safer, more effective, and compatible with long-term patient treatment.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cstrong>\u003Cspan style=\"font-family: Montserrat;\">CDR Grafting: Preserving Antigen Recognition\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat;\">The most common humanization approach is complementarity-determining region (CDR) grafting. This method involves transferring the antigen-binding CDRs from a non-human antibody onto a human immunoglobulin framework. Because the CDRs dictate specificity and binding affinity, careful selection of the recipient framework is essential to maintain functional activity.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat;\">Successful CDR grafting requires analyzing structural compatibility and identifying key residues within the framework that support proper CDR conformation. Advanced computational modeling, molecular dynamics simulations, and structural prediction tools are often used to refine grafts, ensuring that the humanized antibody maintains its original binding properties without introducing steric clashes or instability.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cstrong>\u003Cspan style=\"font-family: Montserrat;\">Framework Optimization for Stability and Expression\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat;\">Framework regions are not merely scaffolding; they influence antibody folding, stability, and expression. In humanization, certain residues in the original framework may be retained if they are critical for maintaining the CDR conformation. Conversely, modifying non-essential residues to match a human germline sequence reduces immunogenic potential.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat;\">Optimized frameworks enhance thermostability, solubility, and expression levels, enabling reliable large-scale production. By combining framework optimization with CDR grafting, developers can produce antibodies that are both functionally active and manufacturable at clinical and commercial scales.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cstrong>\u003Cspan style=\"font-family: Montserrat;\">Backmutation and Fine-Tuning Affinity\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat;\">Sometimes humanization can slightly reduce antigen-binding affinity. To address this, backmutation strategies are employed, where specific non-human residues critical for binding are reintroduced into the humanized antibody. This fine-tuning ensures that the therapeutic maintains its efficacy while minimizing immunogenicity. Iterative cycles of design, modeling, and experimental validation are commonly used to achieve the optimal balance between affinity and human-like properties.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cstrong>\u003Cspan style=\"font-family: Montserrat;\">Reducing Immunogenicity and Enhancing Safety\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat;\">The ultimate goal of humanization is to reduce immunogenicity in patients. Non-human sequences are recognized as foreign by the human immune system, potentially triggering anti-drug antibodies (ADAs) that can neutralize the therapeutic or provoke adverse reactions. By aligning the antibody sequence with human germline frameworks, humanized antibodies elicit fewer immune responses, increasing safety and improving clinical success rates.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat;\">In addition to immunogenicity, humanization can improve pharmacokinetics and tissue distribution. Human-like antibodies interact predictably with neonatal Fc receptors (FcRn), enhancing serum half-life and reducing the need for frequent dosing.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cstrong>\u003Cspan style=\"font-family: Montserrat;\">Applications in Modern Therapeutics\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat;\">Humanized antibodies have become a cornerstone of modern biologics. They are widely used in monoclonal antibody therapies for cancer, inflammatory diseases, infectious diseases, and rare genetic disorders. Humanization also supports next-generation formats, including bispecific antibodies, antibody-drug conjugates (ADCs), and Fc-engineered variants, where safety, stability, and predictable immune interactions are crucial for success.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat;\">Antibody humanization is a powerful tool for transforming research antibodies into clinically viable therapeutics. Through CDR grafting, framework optimization, and backmutation strategies, developers can reduce immunogenicity, maintain binding affinity, and improve pharmacokinetics. This process underpins the development of safer, more effective monoclonal antibodies that meet the rigorous demands of modern drug development.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat;\">Led by an experienced team of recombinant antibody and protein scientists, GenCefe Biotech provides comprehensive solutions for \u003C\u002Fspan>\u003Ca href=\"https:\u002F\u002Fwww.gencefebio.com\u002FproductsAndservices\u002F10-Recombinant_Antibody.html\" style=\"text-decoration: underline; font-family: Montserrat; color: rgb(79, 129, 189);\">\u003Cspan style=\"font-family: Montserrat; color: rgb(79, 129, 189);\">recombinant antibody and protein production\u003C\u002Fspan>\u003C\u002Fa>\u003Cspan style=\"font-family: Montserrat;\">. Supported by our well-established \u003C\u002Fspan>\u003Ca href=\"https:\u002F\u002Fwww.gencefebio.com\u002FproductsAndservices\u002F9-Gene_Synthesis_and_Related_Services.html\" style=\"text-decoration: underline; font-family: Montserrat; color: rgb(79, 129, 189);\">\u003Cspan style=\"font-family: Montserrat; color: rgb(79, 129, 189);\">gene synthesis\u003C\u002Fspan>\u003C\u002Fa>\u003Cspan style=\"font-family: Montserrat; color: rgb(79, 129, 189);\"> \u003C\u002Fspan>\u003Cspan style=\"font-family: Montserrat;\">platform and advanced CHO and HEK293 mammalian expression systems, we deliver end-to-end services—from gene synthesis and expression vector construction to \u003C\u002Fspan>\u003Ca href=\"https:\u002F\u002Fwww.gencefebio.com\u002FproductsAndservices\u002F10-Recombinant_Antibody.html\" style=\"text-decoration: underline; font-family: Montserrat; color: rgb(79, 129, 189);\">\u003Cspan style=\"font-family: Montserrat; color: rgb(79, 129, 189);\">antibody and protein purification\u003C\u002Fspan>\u003C\u002Fa>\u003Cspan style=\"font-family: Montserrat;\">, as well as large-scale manufacturing.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr\u002F>\u003C\u002Fp>","2026-02-03 00:00:00","Antibody Humanization Strategies for Therapeutics: Reducing Immunogenicity and Enhancing Efficacy | GenCefe Biotech","Explore antibody humanization techniques and their benefits in reducing immunogenicity, improving pharmacokinetics, and enabling safer, more effective therapeutic antibodies.","antibody humanization, therapeutic antibodies, reduced immunogenicity, CDR grafting, framework optimization, recombinant antibodies, GenCefe Biotech","2026-02-03 17:10:23","150,149,148,147,146",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":346,"categoryName":186,"title":347,"imgUrl":348,"content":349,"excerpt":78,"publishDate":350,"seoTitle":351,"seoDesc":352,"seoKeywords":353,"createDate":354,"sort":9,"relatedPostIds":355,"firstServiceProductId":185,"secondServiceProductIds":299,"relatedPost":8,"productService":8,"allSecondProductService":8,"twoSecondProductService":8},154,"Bispecific Antibodies: Design Strategies and Therapeutic Applications","http:\u002F\u002Fmanage.gencefebio.com\u002Fprofile\u002Fupload\u002F2026\u002F07\u002F06\u002F09_20260706150130A293.jpg","\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">\u003Cimg src=\"http:\u002F\u002Fmanage.gencefebio.com\u002Fprofile\u002Fupload\u002F2026\u002F07\u002F06\u002F09_20260706150136A294.jpg\" title=\" antibody engineering, dual-target therapeutics,\" alt=\" antibody engineering, dual-target therapeutics,\" width=\"100%\"\u002F>\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Bispecific antibodies (bsAbs) represent a rapidly growing class of next-generation therapeutics capable of simultaneously engaging two distinct antigens or epitopes. This dual-targeting capability offers unprecedented flexibility for modulating complex biological pathways, redirecting immune cells toward tumor cells, or enhancing specificity in inflammatory diseases. The development of bispecific antibodies requires sophisticated engineering to ensure correct chain pairing, maintain structural stability, and preserve biological activity. As clinical applications expand, understanding the design principles and potential therapeutic benefits of bsAbs is essential for researchers and developers.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cstrong>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Design Strategies for Bispecific Antibodies\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Designing a bispecific antibody involves several key challenges, primarily ensuring correct heavy-light chain pairing and maintaining structural integrity. Multiple formats have been developed to address these challenges, including tandem single-chain variable fragments (scFv), dual-variable domain antibodies, and IgG-like bispecifics with engineered Fc regions. Each format has unique advantages in terms of stability, half-life, effector function, and manufacturability.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Molecular engineering often focuses on optimizing domain interfaces, introducing mutations that favor correct pairing, and minimizing misfolded or aggregated species. Advanced computational modeling and high-throughput screening are commonly used to predict and validate structural compatibility, enabling the generation of functionally active bispecific molecules.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cstrong>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Functional Advantages of Dual-Targeting\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Bispecific antibodies offer functional advantages that conventional monospecific antibodies cannot achieve. In oncology, one arm can engage a tumor-associated antigen while the other recruits immune effector cells such as T cells or NK cells. This approach enables precise immune redirection, enhancing tumor cell killing while minimizing off-target toxicity. In autoimmune or inflammatory diseases, bispecifics can simultaneously block two signaling pathways, providing synergistic therapeutic effects that are difficult to achieve with separate antibodies.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">The dual-targeting mechanism also allows for fine-tuning of immune responses and improved therapeutic windows, reducing side effects and potentially enabling lower dosing regimens. This versatility has led to a surge of clinical trials exploring bispecific antibodies across a range of diseases.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cstrong>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Engineering Challenges and Solutions\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Despite their promise, bispecific antibodies pose several engineering challenges. Correct chain pairing is critical to prevent misassembled products, and maintaining stability can be difficult due to increased structural complexity. Glycosylation, solubility, and aggregation are additional factors that must be carefully controlled.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Several strategies address these challenges. Knobs-into-holes mutations in Fc regions improve heterodimer formation, while domain swapping and charge-pair engineering ensure correct heavy-light chain interactions. Glycoengineering and expression optimization further enhance stability and solubility. By integrating these approaches, developers can produce bispecific antibodies with high yield, functional potency, and long-term stability suitable for clinical use.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cstrong>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Clinical Applications of Bispecific Antibodies\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Bispecific antibodies are particularly prominent in cancer immunotherapy. Molecules that engage CD3 on T cells and a tumor antigen can directly recruit cytotoxic T cells to tumor cells, enabling potent anti-tumor activity. Other applications include targeting immune checkpoints, inflammatory mediators, or infectious pathogens.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Beyond oncology, bispecific antibodies are explored for autoimmune disease, viral neutralization, and regenerative medicine. The ability to simultaneously modulate two biological targets offers therapeutic strategies that are otherwise difficult to achieve with conventional monoclonal antibodies or combination therapies.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cstrong>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Future Trends and Perspectives\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">The future of bispecific antibodies is driven by improved molecular design, AI-assisted modeling, and novel expression platforms. Researchers are exploring multispecific formats, conditional bispecifics, and modular designs that can adapt to dynamic therapeutic needs. As production technologies advance, scalable and cost-effective manufacturing solutions are becoming more feasible, accelerating clinical development and commercialization. Bispecific antibodies are set to play a central role in the next generation of precision therapeutics, offering unprecedented versatility and efficacy.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Led by an experienced team of recombinant antibody and protein scientists, GenCefe Biotech provides comprehensive solutions for \u003C\u002Fspan>\u003Ca href=\"https:\u002F\u002Fwww.gencefebio.com\u002FproductsAndservices\u002F10-Recombinant_Antibody.html\" style=\"text-decoration: underline; font-family: Montserrat; font-size: 16px; color: rgb(79, 129, 189);\">\u003Cspan style=\"font-family: Montserrat; font-size: 16px; color: rgb(79, 129, 189);\">recombinant antibody and protein production\u003C\u002Fspan>\u003C\u002Fa>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">. Supported by our well-established \u003C\u002Fspan>\u003Ca href=\"https:\u002F\u002Fwww.gencefebio.com\u002FproductsAndservices\u002F9-Gene_Synthesis_and_Related_Services.html\" style=\"text-decoration: underline; font-family: Montserrat; font-size: 16px; color: rgb(79, 129, 189);\">\u003Cspan style=\"font-family: Montserrat; font-size: 16px; color: rgb(79, 129, 189);\">gene synthesis\u003C\u002Fspan>\u003C\u002Fa>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\"> platform and advanced CHO and HEK293 mammalian expression systems, we deliver end-to-end services—from gene synthesis and expression vector construction to \u003C\u002Fspan>\u003Ca href=\"https:\u002F\u002Fwww.gencefebio.com\u002FproductsAndservices\u002F10-Recombinant_Antibody.html\" style=\"text-decoration: underline; font-family: Montserrat; font-size: 16px; color: rgb(79, 129, 189);\">\u003Cspan style=\"font-family: Montserrat; font-size: 16px; color: rgb(79, 129, 189);\">antibody and protein purification\u003C\u002Fspan>\u003C\u002Fa>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">, as well as large-scale manufacturing.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr\u002F>\u003C\u002Fp>","2026-02-10 00:00:00","Bispecific Antibodies: Engineering Strategies, Functional Advantages, and Clinical Applications | GenCefe Biotech","Explore the design strategies and therapeutic applications of bispecific antibodies, including formats, engineering challenges, and their potential in oncology and immunotherapy.","bispecific antibodies, antibody engineering, dual-target therapeutics, recombinant antibodies, antibody formats, immunotherapy, GenCefe Biotech","2026-02-10 14:20:01","152,151,150,149,148",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":185,"title":186,"excerpt":78,"content":357,"seoTitle":358,"seoDesc":359,"seoKeywords":360,"sort":215,"createDate":361,"secondColor":362,"showOrderPic":5,"homeState":49,"homePic":363,"homeTitle":186,"homeDesc":364,"homeSort":31,"orderDesc":78,"orderUrl":365,"email":284,"phone":285,"onlineFormUrl":365,"serviceFeatureList":8,"productServiceSubList":8},"\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat;\">Led by an experienced team of recombinant antibody and protein scientists, GenCefe Biotech provides comprehensive solutions for \u003C\u002Fspan>\u003Ca href=\"https:\u002F\u002Fwww.gencefebio.com\u002FproductsAndservices\u002F10-Recombinant_Antibody.html\" style=\"font-family: Montserrat; text-decoration: underline;\">\u003Cspan style=\"font-family: Montserrat;\">recombinant antibody production\u003C\u002Fspan>\u003C\u002Fa>\u003Cspan style=\"font-family: Montserrat;\"> and protein production. Supported by our well-established gene synthesis platform and advanced CHO and HEK293 mammalian expression systems, we deliver end-to-end services—from gene synthesis and expression vector construction to antibody and protein purification, as well as large-scale manufacturing.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat;\">We offer efficient, stable, and customizable antibody expression solutions for academic institutions and biopharmaceutical companies, enabling smooth transitions from fundamental research to drug development. With our robust technical systems and extensive project experience, GenCefe is committed to accelerating antibody R&D and enhancing translational efficiency for innovative discoveries.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr\u002F>\u003C\u002Fp>\u003Cp>\u003Cstrong>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">GenCefe Recombinant Antibody & Protein Solution\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp>\u003Cstrong>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">\u003Cimg src=\"http:\u002F\u002Fmanage.gencefebio.com\u002Fprofile\u002Fupload\u002F2025\u002F11\u002F20\u002F图片3_20251120164845A006.png\" title=\"\" alt=\"\"\u002F>\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp style=\"text-align:center\">\u003Cbr\u002F>\u003C\u002Fp>\u003Cp>\u003Cbr\u002F>\u003C\u002Fp>","Recombinant Antibody | Fast Turnaround from 1 Week-GenCefe","GenCefe provides recombinant antibody expression and purification for antibody development, therapeutic research, antigen binding studies, and immunoassays.","Recombinant Antibody Expression, Recombinant Monoclonal Antibody Expression, Recombinant mAb Production, Custom Recombinant Antibody, Antibody Expression Services","2025-11-20 09:55:49","#185192","https:\u002F\u002Fmanage.gencefebio.com\u002Fprofile\u002Fupload\u002F2025\u002F11\u002F24\u002F抗体-蓝_20251124160642A001.png","Delivering fast, high-quality recombinant antibody solutions.","https:\u002F\u002Fforms.zohopublic.com\u002Fgencefebiotech1\u002Fform\u002FRecombinantAntibodyQuoteForm\u002Fformperma\u002FuJSYaxh8gmZuKHDp5D3hdXdkonkzBZ6lhYmlygYkmP8",[367,368],{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":189,"parentId":185,"title":190,"subTitle":78,"excerpt":78,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"sort":8,"hotState":5,"newState":49,"type":50,"customerTestimonials":8,"productCatalog":8,"relatedTitles":8,"productService":8,"customerTestimonialsList":8,"relatedTitlesList":8,"serviceFeatureSubList":8,"productCatalogList":8},{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":192,"parentId":185,"title":193,"subTitle":78,"excerpt":78,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"sort":8,"hotState":5,"newState":5,"type":50,"customerTestimonials":8,"productCatalog":8,"relatedTitles":8,"productService":8,"customerTestimonialsList":8,"relatedTitlesList":8,"serviceFeatureSubList":8,"productCatalogList":8},[370,371],{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":189,"parentId":185,"title":190,"subTitle":78,"excerpt":78,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"sort":8,"hotState":5,"newState":49,"type":50,"customerTestimonials":8,"productCatalog":8,"relatedTitles":8,"productService":8,"customerTestimonialsList":8,"relatedTitlesList":8,"serviceFeatureSubList":8,"productCatalogList":8},{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":192,"parentId":185,"title":193,"subTitle":78,"excerpt":78,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"sort":8,"hotState":5,"newState":5,"type":50,"customerTestimonials":8,"productCatalog":8,"relatedTitles":8,"productService":8,"customerTestimonialsList":8,"relatedTitlesList":8,"serviceFeatureSubList":8,"productCatalogList":8}]